BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31135491)

  • 1. Causes of premature mortality in schizophrenia: a review of literature published in 2018.
    Laursen TM
    Curr Opin Psychiatry; 2019 Sep; 32(5):388-393. PubMed ID: 31135491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life expectancy and cardiovascular mortality in persons with schizophrenia.
    Laursen TM; Munk-Olsen T; Vestergaard M
    Curr Opin Psychiatry; 2012 Mar; 25(2):83-8. PubMed ID: 22249081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess early mortality in schizophrenia.
    Laursen TM; Nordentoft M; Mortensen PB
    Annu Rev Clin Psychol; 2014; 10():425-48. PubMed ID: 24313570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Excess mortality of schizophrenia].
    Wernlund AG; Aagaard J
    Ugeskr Laeger; 2015 Mar; 177(13):V10140556. PubMed ID: 25822814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of antipsychotics on mortality in schizophrenia: systematic review.
    Weinmann S; Read J; Aderhold V
    Schizophr Res; 2009 Aug; 113(1):1-11. PubMed ID: 19524406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder.
    Laursen TM; Munk-Olsen T; Gasse C
    PLoS One; 2011; 6(9):e24597. PubMed ID: 21935426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia, neuroleptic medication and mortality.
    Joukamaa M; Heliövaara M; Knekt P; Aromaa A; Raitasalo R; Lehtinen V
    Br J Psychiatry; 2006 Feb; 188():122-7. PubMed ID: 16449697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of mortality in schizophrenia: An updated review of European studies.
    Piotrowski P; Gondek TM; Królicka-Deręgowska A; Misiak B; Adamowski T; Kiejna A
    Psychiatr Danub; 2017 Jun; 29(2):108-120. PubMed ID: 28636568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study.
    De Hert M; Correll CU; Cohen D
    Schizophr Res; 2010 Mar; 117(1):68-74. PubMed ID: 20060684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess mortality of schizophrenia. A meta-analysis.
    Brown S
    Br J Psychiatry; 1997 Dec; 171():502-8. PubMed ID: 9519087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
    Saha S; Chant D; McGrath J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1123-31. PubMed ID: 17909124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987-2010.
    Ösby U; Westman J; Hällgren J; Gissler M
    Eur J Public Health; 2016 Oct; 26(5):867-871. PubMed ID: 26748100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paradox of premature mortality in schizophrenia: new research questions.
    Wildgust HJ; Hodgson R; Beary M
    J Psychopharmacol; 2010 Nov; 24(4 Suppl):9-15. PubMed ID: 20923916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study.
    Bitter I; Czobor P; Borsi A; Fehér L; Nagy BZ; Bacskai M; Rakonczai P; Hegyi R; Németh T; Varga P; Gimesi-Országh J; Fadgyas-Freyler P; Sermon J; Takács P
    Eur Psychiatry; 2017 Sep; 45():97-103. PubMed ID: 28753464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of decreased life expectancy over the life span in bipolar disorder.
    Kessing LV; Vradi E; McIntyre RS; Andersen PK
    J Affect Disord; 2015 Jul; 180():142-7. PubMed ID: 25909752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
    Ryan MC; Thakore JH
    Life Sci; 2002 Jun; 71(3):239-57. PubMed ID: 12034344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials.
    Schneider-Thoma J; Efthimiou O; Huhn M; Krause M; Reichelt L; Röder H; Davis JM; Salanti G; Leucht S
    Lancet Psychiatry; 2018 Aug; 5(8):653-663. PubMed ID: 30042077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in schizophrenia.
    Hasnain M; Vieweg WV; Mezuk B
    J Psychopharmacol; 2011 Jun; 25(6):846-7. PubMed ID: 21421641
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.